Alerts will be sent to your verified email
Verify Email
RPGLIFE
|
RPG Life Sciences
|
Panacea Biotec
|
Sequent Scientific
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Domestic Sales Growth - YoY
|
-11.18 % | n/a | n/a |
|
R&D as a % of Total Sales
|
2.34 % | 6.74 % | 0.0 |
|
Financials
|
|||
|
5 yr Average ROE
|
16.75 % | 19.34 % | 3.75 % |
|
5yr average Equity Multiplier
|
1.43 | 2.01 | 2.1 |
|
5yr Average Asset Turnover Ratio
|
1.3 | 0.39 | 0.87 |
|
5yr Avg Net Profit Margin
|
9.23 % | 20.95 % | 2.4 % |
|
Price to Book
|
6.49 | 1.01 | 4.77 |
|
P/E
|
27.76 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
-46.65 Days | -83.17 Days | 61.25 Days |
|
Inventory Days
|
63.59 Days | 118.8 Days | 70.72 Days |
|
Days Receivable
|
23.17 Days | 54.62 Days | 84.11 Days |
|
Days Payable
|
141.25 Days | 284.35 Days | 118.6 Days |
|
5yr Average Interest Coverage Ratio
|
17.24 | 2.91 | 2.9 |
|
5yr Avg ROCE
|
23.6 % | -10.17 % | 9.0 % |
|
5yr Avg Operating Profit Margin
|
17.39 % | -2.87 % | 10.83 % |
|
5 yr average Debt to Equity
|
0.06 | 0.41 | 0.46 |
|
5yr CAGR Net Profit
|
44.3 % | n/a | n/a |
|
5yr Average Return on Assets
|
11.89 % | 7.46 % | 1.98 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.81 % | 73.59 % | 52.79 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.74 % | 0.0 | -1.07 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
1.47 % | -1.27 % | 2.48 % |
|
RPG Life Sciences
|
Panacea Biotec
|
Sequent Scientific
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
Therapeutic Area Break-Up
|
